Company: SCLXW
Filing Date: 2025-12-29
Form Type: 424B3
Source: 0001193125-25-335429
Chunk: 605

Company: Scilex Holding Co
Filing Date: 2025-12-29
Form: 424B3
Chunk 605
---
 into the Gloperba-Elyxyb Royalty Purchase Agreement (as described below).

On
July 22, 2025, the Company entered into Warrant Exchange Agreements (each, a “Warrant Exchange Agreement” and collectively, the “Warrant Exchange Agreements”) with certain holders of the Company’s then-existing
Tranche B warrants (such certain holders (excluding Oramed), the “Exchanging Warrant Holders”) to purchase shares of Common Stock (such Tranche B warrants held by the Exchanging Warrant Holders, the “Existing Tranche B
Warrants”). Pursuant to the Warrant Exchange Agreements, the Company and the Exchanging Warrant Holders, in reliance on Section 3(a)(9) of the Securities Act, effected a voluntary securities exchange whereby the Exchanging Warrant Holders
exchanged the Existing Tranche B Warrants, which are currently exercisable for an aggregate of 107,142 shares of Common Stock at an exercise price of $36.40 per share, originally issued pursuant to the Tranche B Securities Purchase Agreement, for
warrants to purchase an aggregate of 500,000 shares of Common Stock (the “New Tranche B Warrants”) at an exercise price of $40.00 per share (the “Exercise Price”). The New Tranche B Warrants shall be immediately exercisable,
but may only be exercised on a cash basis on or after the earlier of (i) the date that is 90 days following the Closing Date (as defined in the Warrant Exchange Agreements), and (ii) the initial date after the date of the Warrant Exchange
Agreements that a registration statement is effective and available for the issuance of the shares of Common Stock underlying the New Tranche B Warrants to the holders of the New Tranche B Warrants (or the resale of shares of Common Stock underlying
the New Tranche B Warrants); provided, however, the New Tranche B Warrants may only be exercised on a cashless basis if there is no registration statement to cover the issuance of the shares of Common Stock underlying the New Tranche B Warrants
or the resale of such shares. The New Tranche B Warrants shall have an expiration date of October 8, 2029. The Company recognized a loss in the amount of $1.1 million in relation to this exchange transaction. As of September 30, 2025,
there were 500,000 New Tranche B Warrants outstanding.